Lung Cancer Screening: Expanding Criteria for Better Detection and Survival
Lung cancer screening is a critical tool in the fight against this deadly disease, but current eligibility criteria may be missing a significant portion of patients at risk. A recent study highlights the potential of age-based screening to detect more cases and improve survival rates.
The Current Shortfall
In a study of 997 adults diagnosed with lung cancer between 2018 and 2023, only 35.1% met the current US Preventive Services Task Force criteria for lung cancer screening with low-dose CT. This means that a staggering 64.9% of eligible patients were missed. Interestingly, those who qualified were more likely to be male, White, heavier smokers, and had worse survival rates (median 4.4 years) compared to those who wouldn't have qualified (median 9.5 years).
The Case for Age-Based Screening
The study explored the potential of expanding screening criteria. By broadening eligibility to ages 40-85 years, at least ten pack-years of smoking, and no upper limit on time since cessation, the proportion of detectable cancers increased to 62.1%. However, this still left nearly four in ten patients outside the net. In contrast, an age-based approach offering low-dose CT to all adults aged 40-85 years captured a remarkable 93.9% of cancers.
Cost-Effectiveness and Equity
Age-based lung cancer screening is estimated to prevent 26,124 deaths annually in the US at a cost of $101,000 per life saved. This is significantly more cost-effective than existing national screening programs for breast and colorectal cancer. Sensitivity analyses strongly suggest that age-based strategies remain cost-effective across various assumptions. The authors conclude that shifting from strict smoking history thresholds to age-focused screening could significantly improve early detection, reduce disparities for women and never smokers, and provide better value for health systems.
Moving Forward
This research highlights the need to reevaluate lung cancer screening criteria. By expanding eligibility to include a broader age range and considering smoking history more flexibly, we can potentially save more lives and ensure equitable access to this life-saving tool.
